CTLA4 and neoplasm: It has been reported that pseudo-progression with an initial increase in total tumor burden; stable disease state with a slow steady decline in total tumor volume; or a presence of new lesions, were all associated with patients responding to anti-CTLA-4 treatment and were linked to favorable survival (23).